Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy
ConditionGastric Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorGangnam Severance Hospital
About this trial
The study evaluates the efficacy of Ropivacaine-Poloxamer 407 hydrogel in reducing postoperative pain following open gastrectomy.
Eligibility criteria
Qualifiers
Patients with a histologically confirmed diagnosis of gastric adenocarcinoma prior to surgery.
Patients who have undergone a complete surgical resection (R0 resection).
Patients with an ASA (American Society of Anesthesiologists) score of 3 or below.
Patients aged 20 years or older.
Disqualifiers
Patients under 19 years of age.
Presence of ascites or peritoneal metastasis.
Patients who have undergone preoperative chemotherapy or radiotherapy.
Diagnosis of malignancies other than gastric cancer.
Trial design
Treatments tested in this trial
- Arm I (Peritoneal application group)
- Arm II (Subcutaneous injection group)
Treatment groups
48 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov